Latest News
EBC Introduces the Seal of Responsible Neurotechnologies
The European Brain Council is pleased to introduce the Seal of Responsible Neurotechnologies, a voluntary ethical label to address unmet governance needs in the neurotechnology sector. Neurotechnologies, encompassing devices and procedures that interact with the brain and nervous system, are increasingly deployed outside clinical settings, raising ethical questions about human agency, mental privacy and freedom of thought that existing [...]
EBC at the 34th European Congress of Psychiatry in Prague
EBC at the 34th European Congress of Psychiatry The European Brain Council (EBC) was proud to participate in the 34th European Congress of Psychiatry, organised by the European Psychiatric Association (EPA) and held at the Prague Congress Centre from 28 to 31 March 2026. Gathering thousands of mental health professionals, researchers, policymakers and patient [...]
Event Highlights: Rethinking Schizophrenia in Germany – A Brain Health Approach to Schizophrenia Prevention and Care
Introduction Following the recommendations set out in the Rethinking Schizophrenia Care Pathway in Europe study paper, the next phase of the project — Country Profiles: Beyond Mental Health – A Brain Health Approach to Schizophrenia Prevention and Care — focuses on analysing country-specific models of care and identifying opportunities to improve prevention, early detection and integrated care across Europe. After a roundtable meeting in Poland in June [...]
Brain Health Day 2026: Building Momentum for a Coordinated European Vision for the Brain
On 18 March 2026, policymakers, researchers, clinicians, patient representatives and industry leaders gathered in Brussels for Brain Health Day: Prevention, Policy, Progress - a full day of activities organised by the Brain Health Mission, the European Academy of Neurology with the European Brain Council and the Federation of European Neuroscience Societies. Taking place during the 2026 Brain Awareness Week, [...]
EBC Questions the Relevance of NAMS as Part of the Biotech Act
The European Brain Council (EBC) welcomes the first part of the EU Biotech Act as proposed by the European Commission. It is indeed regarded as timely initiative to strengthen Europe’s capacity to translate its excellence in science into tangible health solutions. In particular, its aims to strengthen the EU’s biotechnology and biomanufacturing ecosystem, with an initial and explicit focus on health biotechnology, by reducing regulatory fragmentation, accelerating [...]
Event Highlights – Rare Disease Day 2026
The European Brain Council (EBC) Rare Disease Day Event convened clinicians, patients, policymakers, researchers and industry leaders to advance coordination on rare diseases in Europe. Building on the Rare Brain Disease (RBD) Ecosystem, the event sought to identify systemic gaps, strengthen research–care integration, and review EU regulatory and research developments. A key outcome was laying the foundations for scaling [...]
Event Report – 2026 SANT Hearing
On 24 February 2026, the European Parliament Committee on Public Health (SANT) held a Public Hearing on ‘Brain health: Policy challenges and opportunities to manage neurological diseases’. The European Brain Council (EBC) was pleased to be invited to take part in this essential discussion through the contribution of its President-Elect, Professor Sameer Zuberi, as well as Board Member and [...]
EBC Launches ‘Rethinking Neurofibromatosis Type 1’ to Propose Policy Recommendations for an Improved Care Pathway
The European Brain Council (EBC), in collaboration with Neurofibromatosis Patients United (NFPU), is pleased to launch the 'Rethinking Neurofibromatosis Type 1' project on the occasion of EBC's Rare Disease Day event, held on February 24th, 2026 in Brussels. Neurofibromatosis is a rare genetic disease, that includes three different diseases that affect over 250,000 people in Europe. All are genetic [...]
EBC Launches ‘Rethinking Myasthenia Gravis’ Advocacy Paper
The European Brain Council (EBC), in collaboration with the Institute of Management of Scuola Superiore de Sant'Anna, is pleased to launch the 'Rethinking Myasthenia Gravis' Advocacy Paper on the occasion of EBC's Rare Disease Day event, held on February 24th, 2026 in Brussels. Rethinking Myasthenia Gravis (MG) is a research-driven project that will offer policy recommendations to make tangible [...]
Press Release – Brain Health: Policy Challenges & Opportunities to Manage Neurological Diseases
Brussels, 24 February 2026 – Today, the European Parliament Committee on Public Health (SANT) will hold a Public Hearing on ‘Brain health: Policy challenges and opportunities to manage neurological diseases’. Brain disorders, neurological and mental alike, represent one of the most pressing health challenges facing the European Union. At least one in three Europeans currently lives with a brain [...]